Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Peripheral immune suppression of mammalian retinal regeneration
Author Affiliations & Notes
  • Nicolai Blasdel
    Biological Structure, University of Washington, Seattle, Washington, United States
  • Levi Todd
    Ophthalmology and Visual Sciences, SUNY The State University of New York, Albany, New York, United States
  • Thomas A Reh
    Biological Structure, University of Washington, Seattle, Washington, United States
  • Footnotes
    Commercial Relationships   Nicolai Blasdel None; Levi Todd None; Thomas Reh None
  • Footnotes
    Support  NEI Grant R01EY021482, NEI Grant K99EY033402
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3457. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nicolai Blasdel, Levi Todd, Thomas A Reh; Peripheral immune suppression of mammalian retinal regeneration. Invest. Ophthalmol. Vis. Sci. 2024;65(7):3457.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Blinding diseases of the retina have few effective treatments. While non-mammalian vertebrates, such as fish, can regenerate retina and restore vision, mammals cannot. We previously found that driving the proneural transcription factor Ascl1 stimulates neurogenesis from mammalian Müller Glia (MG). We also reported that inflammation after cell death limits the neurogenic capacity of mammalian MG. In this work, we characterize the peripheral immune response to retinal injury and find that monocyte-derived signals restrict the regenerative capacity of MG in adult mice.

Methods : To characterize the immune response after NMDA-induced injury, scRNA-sequencing was performed on FACS-purified CD45 positive cells 7 days after damage. CCR2:RFP transgenic mice were used to visualize monocyte infiltration.

To study how monocytes impact retinal regeneration, we used a mouse with inducible expression of Ascl1 in MG and deletion of the CCR2 receptor (Glast-CreER/LNL-tTA/TetO-Ascl1-GFP/CCR2RFP/RFP). To induce regeneration, intraperitoneal tamoxifen is used to induce Ascl1 in MG, followed by intravitreal injections of NMDA to elicit death of retinal ganglion cells and intravitreal Trichostatin-A to promote chromatin accessibility and neurogenesis. Three weeks later, retinas were harvested for immunofluorescence. The number of MG-derived neurons (GFP+/Otx2+) was compared between CCR2 sufficient and knockout mice. FACS-purified MG and immune cells were also analyzed using scRNA-seq and the Seurat and CellChatDB software.

Results : We found that monocytes invade into the retina after NMDA injury, and blocking this invasion significantly increased MG-derived neurogenesis. scRNA-seq analysis using CellChatDB produced a ranked list of ligand-receptor interactions between the Monocytes and MG, with the Secreted Phosphoprotein 1 (Spp1) pathway amongst the strongest. The addition of recombinant Spp1 in monocyte-deficient retinas reversed the neurogenic increase seen with monocyte depletion. This suggests that Spp1 is a key monocyte-derived signal that inhibits MG neurogenesis.

Conclusions : This work implicates peripheral immune invasion as a significant factor in MG reprogramming strategies. We find that monocytes release signals that are detrimental to MG neurogenesis. A more thorough understanding of the interactions between glia and the immune system may guide the development of novel therapeutic approaches.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×